InvestorsHub Logo
Followers 0
Posts 13277
Boards Moderated 0
Alias Born 05/06/2016

Re: None

Thursday, 01/05/2017 7:34:45 PM

Thursday, January 05, 2017 7:34:45 PM

Post# of 42929
Did anyone read this PR last month?

A little slap on the hand from the SEC (maybe), and he’s off and running - left investors in the dust.
Pumping like crazy on his Facebook page.


Milford, PA -- (ReleaseWire) -- 12/12/2016 --Ken Manzo, the founder of Manzo Pharmaceuticals, LLC., (OTC:MNZO) is pleased to announce the launch of a new and unique patented probiotic, "Lacto-Freedom Probiotic". It stays in the intestines and aids in the digestion of lactose containing foods, designed specifically for people who do not properly digest lactose in dairy products. Lacto-Freedom™ probiotic prevents abdominal pain, gas, abdominal bloating, diarrhea, and nausea that may result from lactose sensitivity. It is taken for only 7 days and the lactose digesting effects last for months.



http://rwire.com/750512